These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15941194)

  • 1. In vitro diagnostics industry news.
    Med Device Technol; 2005 May; 16(4):22-4. PubMed ID: 15941194
    [No Abstract]   [Full Text] [Related]  

  • 2. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 3. Not for the chicken-hearted.
    Nat Biotechnol; 2006 Aug; 24(8):870. PubMed ID: 16900108
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid testing in jails.
    AIDS Patient Care STDS; 2004 May; 18(5):321. PubMed ID: 15209065
    [No Abstract]   [Full Text] [Related]  

  • 5. Roche and Igen in shotgun wedding.
    Bouchie A
    Nat Biotechnol; 2003 Sep; 21(9):958. PubMed ID: 12949542
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostics investors think positive.
    Lawrence S
    Nat Biotechnol; 2006 Aug; 24(8):884. PubMed ID: 16900117
    [No Abstract]   [Full Text] [Related]  

  • 7. The need to develop additional rapid HIV tests in the U.S.
    Bean P
    Am Clin Lab; 2001 Jun; 20(5):15-6. PubMed ID: 11505872
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro diagnostic medical devices--the legal context].
    Látal T
    Klin Mikrobiol Infekc Lek; 2009 Dec; 15(6):196-200. PubMed ID: 20077396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of expanded HIV screening.
    Krentz HB; Gill MJ
    Ann Intern Med; 2007 Jul; 147(2):146; author reply 146-7. PubMed ID: 17638723
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic donor screening for anti-HIV in the developing world.
    Mortimer PP; Parry JV
    Vox Sang; 1994; 66(1):88. PubMed ID: 8146992
    [No Abstract]   [Full Text] [Related]  

  • 11. C-Path sets diagnostics standard.
    Roberts J
    Nat Biotechnol; 2009 Mar; 27(3):213. PubMed ID: 19270654
    [No Abstract]   [Full Text] [Related]  

  • 12. 2 billion euro IMI launched with European pharma.
    Hodgson J
    Nat Biotechnol; 2008 Jul; 26(7):717-8. PubMed ID: 18612274
    [No Abstract]   [Full Text] [Related]  

  • 13. The paradox in translational medicine.
    Lippi G; Plebani M; Guidi GC
    Clin Chem; 2007 Aug; 53(8):1553. PubMed ID: 17644795
    [No Abstract]   [Full Text] [Related]  

  • 14. Pooling of urine specimens allows accurate and cost-effective genetic detection of Chlamydia trachomatis in Lithuania and other low-resource countries.
    Butylkina R; Juseviciute V; Kasparaviciene G; Vagoras A; Pagirskas E; Unemo M; Domeika M
    Scand J Infect Dis; 2007; 39(3):209-12. PubMed ID: 17366049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria: new diagnostics for an old problem.
    Duffy P; Fried M
    Am J Trop Med Hyg; 2005 Sep; 73(3):482-3. PubMed ID: 16172466
    [No Abstract]   [Full Text] [Related]  

  • 16. Devil in the details.
    Nat Med; 2008 Feb; 14(2):105-6. PubMed ID: 18256601
    [No Abstract]   [Full Text] [Related]  

  • 17. Researchers see a need for speed in EU trial approvals.
    Cressey D
    Nat Med; 2008 Aug; 14(8):794. PubMed ID: 18685580
    [No Abstract]   [Full Text] [Related]  

  • 18. Europe pledges billions to solve its drug development woes.
    Hughes V
    Nat Med; 2008 Feb; 14(2):107. PubMed ID: 18256603
    [No Abstract]   [Full Text] [Related]  

  • 19. The evolution of in vitro diagnostics manufacturing.
    Madden K
    Med Device Technol; 2000 Oct; 11(8):34-6. PubMed ID: 11185188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity in cancer rates, control programs matches diversity of European Union.
    Zielinski SL
    J Natl Cancer Inst; 2005 Oct; 97(19):1398-9. PubMed ID: 16204685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.